Quantum Genesis AI Corp. (OTC: QGAI) today announced that the Caveat Emptor designation previously applied to the Company’s securities by OTC Markets Group has been removed. The Company worked cooperatively with OTC Markets to provide information and respond to inquiries during the review period, culminating in the removal of the designation.
“We appreciate the time and attention that OTC Markets dedicated to this matter and are pleased that the review process has concluded with the removal of the Caveat Emptor designation,” said Naveen Kulkarni, Chief Executive Officer of Quantum Genesis AI Corp. “Throughout this process, our focus remained on transparency, responsiveness, and constructive engagement. We thank OTC Markets for their professionalism and assistance, and we remain committed to maintaining open communication with our shareholders and the marketplace.”
The removal of the Caveat Emptor designation is significant because it signals to investors that the company has addressed the concerns that led to the label, which OTC Markets applies to stocks with potentially misleading information or other issues. For Quantum Genesis AI, this development could restore investor confidence and improve the liquidity and marketability of its shares. The company continues to advance its strategic initiatives in artificial intelligence, computational modeling, and scientific innovation, while maintaining its commitment to responsible corporate governance and public company compliance.
Quantum Genesis AI intends to continue providing timely updates regarding its business activities and corporate developments through its public disclosures and shareholder communications. For more information and updates, please visit www.qgaicorp.com and the Company’s profile at www.otcmarkets.com/stock/QGAI.
The company is focused on advancing next-generation technologies at the intersection of artificial intelligence, computational modeling, and scientific innovation. Its strategy includes leveraging advanced data-driven tools to support research, discovery, and technology development across emerging sectors while maintaining a commitment to transparency and responsible corporate governance.
